The Board of Pharmacy issued a statement about pharmacist testing of COVID-19 in wake of the federal statement from the Department of Health and Human Services, and updated its list of rules and statutory waivers. New additions include pharmacist authority to substitute albuterol inhalers and the emergency dispensing waiver moved from 30 days to 60 days.
For more information, contact NACDS’ Joel Kurzman at 847-905-0555.